Until a few days ago, The Salt Path was the feel-good story of the decade. It was billed as the true story of a couple who responded to the twin blows of financial ruin and a terminal illness by ...
Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...
Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists ...
TUCSON, Ariz., September 4, 2025 —Critical Path Institute® (C-Path) announced today that its Translational Therapeutics Accelerator (TRxA) program has completed a record year of funding and mentorship ...
Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception, trial modernization, and patient-first evidence. WASHINGTON, Sept. 11, 2025 ...
During his training in clinical dermatology, Thierry Nordmann encountered several patients with a rare, horrifying condition called toxic epidermal necrolysis, or TEN. Widely considered to be the only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback